BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35915746)

  • 1. Are private equity and venture capital helping small and medium-sized enterprises during the COVID-19 pandemic? Evidence from China.
    Yang S
    Econ Anal Policy; 2022 Dec; 76():1-14. PubMed ID: 35915746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Venture Capital on Enterprise Benefit According to the Heterogeneity of Human Capital of Entrepreneur.
    Jin X; Zheng P; Zhong Z; Cao Y
    Front Psychol; 2020; 11():1558. PubMed ID: 32754091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PROTOCOL: Effects of interventions to improve access to financial services for micro-, small- and medium-sized enterprises in low- and middle-income countries: An evidence and gap map.
    Dela Cruz NA; Villanueva ACB; Tolin LA; Disse S; Lensink R; White H
    Campbell Syst Rev; 2023 Sep; 19(3):e1341. PubMed ID: 37415851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Covid-19 impacts the financing in SMEs: Evidence from private firms.
    Yao Z; Liu Y
    Econ Anal Policy; 2023 Jun; ():. PubMed ID: 38620097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venture capital, control rights, and family enterprise growth.
    Pang X; Liu L
    PLoS One; 2021; 16(8):e0256318. PubMed ID: 34407119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between Financial Asset Allocation, Leverage Ratio, and Risk-Taking of Small- and Medium-Sized Enterprises in China: Taking Environment-Related Industries as an Example.
    Chen Q
    J Environ Public Health; 2022; 2022():2431428. PubMed ID: 35733979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of venture capital funds with foreign limited partners investment on enterprise internationalization: evidence from China.
    Feng T; Guo L; Dong J; Wang H
    Heliyon; 2022 Dec; 8(12):e12281. PubMed ID: 36578392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the influence of COVID-19 on the growth of China's small and medium-sized construction enterprises.
    Wang W; Lin W; Bao Z; Dai X; Lin Q
    PLoS One; 2022; 17(6):e0266315. PubMed ID: 35657961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Venture Capital in Enterprise Innovation Under Psychological Capital and Heterogeneity of Entrepreneur Capital.
    Zhang C; Mao D; Wang M
    Front Psychol; 2020; 11():1704. PubMed ID: 32754105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State equity participation and financing constraints of private enterprises in China: Based on the competitive pressure perspective.
    Xiao Q
    PLoS One; 2023; 18(11):e0292817. PubMed ID: 37967071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financial Budgets of Technology-Based SMEs From the Perspective of Sustainability and Big Data.
    Zhang G; Wang T
    Front Public Health; 2022; 10():861074. PubMed ID: 35602131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel enterprises digital transformation influence empirical study.
    Sun X; Sun W; Wang Z
    PLoS One; 2024; 19(1):e0296693. PubMed ID: 38215168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling Latent Structure of Venture Capital Syndication Networks.
    Gu W; Yang A; Lu L; Li R
    Entropy (Basel); 2022 Oct; 24(10):. PubMed ID: 37420525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How innovation funding leads enterprises to engage in research and development: Small and medium enterprises' perspective.
    Sun H; Yang X; Tang X; Peng F
    PLoS One; 2023; 18(7):e0289166. PubMed ID: 37490503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital inclusive finance, financial mismatch and the innovation capacity of small and medium-sized enterprises: Evidence from Chinese listed companies.
    Li W; Pang W
    Heliyon; 2023 Feb; 9(2):e13792. PubMed ID: 36865464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research on the impact of COVID-19 on Chinese small and medium-sized enterprises: Evidence from Beijing.
    Ma Z; Liu Y; Gao Y
    PLoS One; 2021; 16(12):e0257036. PubMed ID: 34882688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does CSR affect the cost of equity capital: Empirical evidence from the targeted poverty alleviation of listed companies in China.
    Yi Y; Xie B; Zhou L; Wei Y
    PLoS One; 2020; 15(2):e0227952. PubMed ID: 32032381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship Between Enterprise Financial Risk and R&D Investment Under the Influence of the COVID-19.
    Li X; Cheng B; Li Y; Duan J; Tian Y
    Front Public Health; 2022; 10():910758. PubMed ID: 35991059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses to COVID-19, small and medium enterprises' corporate social responsibility and psychological capital of employees: From the mediating perspective of affective commitment.
    Jalil MF; Tariq B; Zaheer MA; Ahmed Z
    Heliyon; 2023 Apr; 9(4):e15004. PubMed ID: 37151692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of different government subsidies on total-factor productivity: Evidence from private listed manufacturing enterprises in China.
    Wang D; Sun Y
    PLoS One; 2022; 17(1):e0263018. PubMed ID: 35100316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.